Endocan is a reliable biomarker during continuous renal replacement therapy

被引:1
|
作者
Hureau, Maxence [1 ,2 ,3 ,4 ]
Gaudet, Alexandre [1 ,2 ,3 ,4 ]
Caires, Nathalie De Freitas [1 ,2 ,3 ,5 ]
Parmentier, Erika [1 ,2 ,3 ,4 ]
Poissy, Julien [4 ]
Duburcq, Thibault [4 ]
Lassalle, Philippe [1 ,2 ,3 ,6 ]
Mathieu, Daniel [1 ,2 ,3 ,4 ]
机构
[1] Univ Lille, CIIL, UMR 8204, U1019, F-59000 Lille, France
[2] CNRS, UMR 8204, F-59000 Lille, France
[3] INSERM, U1019, F-59000 Lille, France
[4] CHU Lille, Hop Roger Salengro, Pole Reanimat, F-59000 Lille, France
[5] Lunginnov, 1 Rue Pr Calmette, F-59000 Lille, France
[6] Inst Pasteur, F-59000 Lille, France
来源
CRITICAL CARE | 2019年 / 23卷 / 01期
关键词
D O I
10.1186/s13054-019-2585-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Endocan is a reliable biomarker during continuous renal replacement therapy
    Maxence Hureau
    Alexandre Gaudet
    Nathalie De Freitas Caires
    Erika Parmentier
    Julien Poissy
    Thibault Duburcq
    Philippe Lassalle
    Daniel Mathieu
    Critical Care, 23
  • [2] Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
    Honore, Patrick M.
    De Bels, David
    Attou, Rachid
    Redant, Sebastien
    Gallerani, Andrea
    Kashani, Kianoush
    CRITICAL CARE, 2019, 23
  • [3] Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
    Patrick M. Honore
    David De Bels
    Rachid Attou
    Sebastien Redant
    Andrea Gallerani
    Kianoush Kashani
    Critical Care, 23
  • [4] Alkalemia during continuous renal replacement therapy
    Journois, Didier
    CRITICAL CARE MEDICINE, 2008, 36 (11) : 3119 - 3120
  • [5] Pharmacokinetics during continuous renal replacement therapy
    Keller, E
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (02): : 113 - 117
  • [6] Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy
    Kiers, H. D.
    de Sevaux, R.
    Pickkers, P.
    INTENSIVE CARE MEDICINE, 2011, 37 (11) : 1893 - 1894
  • [7] Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy
    H. D. Kiers
    R. de Sévaux
    P. Pickkers
    Intensive Care Medicine, 2011, 37 : 1893 - 1894
  • [8] Micronutrient Losses during Continuous Renal Replacement Therapy
    Lumlertgul, Nuttha
    Cameron, Lynda K.
    Bear, Danielle E.
    Ostermann, Marlies
    NEPHRON, 2023, 147 (12) : 759 - 765
  • [9] Treatment with echinocandins during continuous renal replacement therapy
    Francisco Javier González de Molina
    MariadeLosÁngeles Martínez-Alberici
    Ricard Ferrer
    Critical Care, 18
  • [10] Drug Dosing During Continuous Renal Replacement Therapy
    Churchwell, Mariann D.
    Mueller, Bruce A.
    SEMINARS IN DIALYSIS, 2009, 22 (02) : 185 - 188